Stock Price
181.70
Daily Change
3.59 2.02%
Monthly
5.36%
Yearly
-32.79%
Q1 Forecast
177.74

CSL reported $2.75B in EBIT for its fiscal semester ending in December of 2024.





Ebit Change Date
aTyr Pharma USD -226.49K 140.85K Sep/2025
CSL USD 2.75B 1.35B Dec/2024